NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹15 Cr | ₹21 Cr | ₹14 Cr | ₹6.50 Cr | ₹16 Cr |
What is the latest Short Term Loans and Advances ratio of NGL FINECHEM ?
Year | Short Term Loans and Advances |
---|---|
Mar2023 | ₹15 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹14 Cr |
Mar2020 | ₹6.50 Cr |
Mar2019 | ₹16 Cr |
How is Short Term Loans and Advances of NGL FINECHEM Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2023 | ₹15 Cr | -29.81 | |
Mar2022 | ₹21 Cr | 51.58 | |
Mar2021 | ₹14 Cr | 114.79 | |
Mar2020 | ₹6.50 Cr | -58.35 | |
Mar2019 | ₹16 Cr | - |
Compare Short Term Loans and Advances of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,464.4 Cr | -6.8% | 10.6% | 76.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -6.8% |
10.6% |
76.3% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses